06 Dec Cannabis: A Panacea?

“Changes in endocannabinoid levels and/or CB2 receptor expressions have been reported in almost all diseases affecting humans, ranging from cardiovascular, gastrointestinal, liver, kidney, neurodegenerative, psychiatric, bone, skin, autoimmune, lung disorders to pain and cancer, and modulating CB2 receptor activity holds tremendous therapeutic potential in these pathologies.”

Pacher P, Mechoulam R, 2011

Source: http://www.ncbi.nlm.nih.gov/pubmed/21295074